Rebalix
Logo iSharesiShares · sheet of 10 September 2026
ETF sheet · official issuer and register data

iShares $ High Yield Corp Bond Enhanced Active UCITS ETF

UHEB · IE000T9NSP89 · USD · domicile Ireland
Bonds · High yield · Broad (all maturities) · North AmericaactiveSFDR art. 6
Comparison benchmark: ICE BofA US High Yield Constrained Index
TER
0.35%+ trans. 0.74%
Fund size
26 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Income
Accumulating
Duration
3.02 yrsmedium (3–7 years)
Launch 4 Dec 2025 · costs from the KID as of 2 Sept 2026 · 259 securities held

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Fund is actively managed and aims to provide investors with a total return, taking into account both capital growth and income returns. The Fund will invest at least 80% of its total assets in sub-investment grade (or where unrated deemed by the Investment Manager (IM) to be of an equivalent rating) (high yield) fixed income securities issued by corporate issuers (i.e. corporate bonds) in developed markets and instruments relating to such securities (namely credit default swaps, currency swaps, futures and forwards), in each case denominated in US…

Performance since series start (in euro) — base 100

4 Dec 202531 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202610699104
High 106 (24 Jun 2026) · low 99 (29 Jan 2026) · last 104. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+4.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · UHEB · IE000T9NSP891
RebalixUHEB · IE000T9NSP89 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication

Fixed income — as declared by the issuer

Issuer page · 20 Aug 2026 · investment-grade share (BBB−/Baa3 and above): 0.3%
Rating breakdown (% of fund)
BBB0.3%BB55.2%B37.8%CCC4.5%CC0.4%C0.0%D0.0%Not rated1.2%Cash and derivatives0.7%
Maturity breakdown (% of fund)
0–1 years10.0%1–2 years5.8%2–3 years23.9%3–5 years40.9%5–7 years12.2%7–10 years4.8%10–15 years0.7%15–20 years1.0%20+ years0.1%

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 259 securities · top-10 weight = 7.9%
Countries (% of fund)
United States78.9%Canada5.1%Japan2.4%Colombia1.6%United Kingdom1.2%
Sectors (% of fund)
Corporates98.4%Cash and/or Derivatives1.6%

Listing venues

ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.

Official documents

Clickable links in the PDF
KID · www.blackrock.com/it/investitori-privati/literature/kiid/eu-priips-ish
Factsheet · www.ishares.com/gls-download/literature/fact-sheet/uheb-ishares-high-y
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares
The live sheet, always up to date
rebalix.com/en/etf/IE000T9NSP89
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · UHEB · IE000T9NSP892